Fundraising Fox

Görlich Gruppe

Family office

Berlin · 3 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Görlich Family Office operates with a multi-generational, disciplined yet risk-tolerant approach to wealth management, drawing on its experience with real estate holding companies to move into new sectors. It always co-invests with its clients, who are experienced in capital participations and able to bear risk. The firm sees biotechnology as a technology transforming medicine and acts as lead investor through its fund vehicle, giving semi-professional and professional investors access to this field. A current example is its lead investment via a special fund in 4TEEN4 Pharmaceuticals GmbH, developing a treatment for cardiogenic shock and an early-detection biomarker.

Invests inBiotechPropTechSector AgnosticBerlinEuropeGermany

Source: firm website, verified Aug 3, 2026.

HQ
Berlin, DE
Leads rounds
Leads
Instruments
Equity
Founded
1984
Tracked investments
2

Team · 3 people

from the firm's website

What they invest in

from 1 of 2 portfolio companies

Biotech ×1Healthtech ×1Medical Devices ×1

HQs:Germany×1

Investments · 2 tracked

founders shown can be your intro path
4TEEN4

Target company of the Görlich GmbH & Co. 1.

4TEEN4 Pharmaceuticals GmbH4teen4.dein

4TEEN4 Pharmaceuticals develops invobenitug (procizumab), a humanized monoclonal antibody that neutralizes circulating Dipeptidyl Peptidase 3 (cDPP3) to reverse life-threatening shock and restore organ function.

BiotechHealthtechMedical Devices

Co-investorsBrandenburg Kapital

Portfolio news

latest coverage across their companies

Frequently asked questions

What sectors does Görlich Gruppe focus on?
Görlich Gruppe focuses on Biotech, PropTech, Sector Agnostic.
Where is Görlich Gruppe located?
Görlich Gruppe is headquartered in Berlin, DE.
Does Görlich Gruppe lead rounds?
Yes, Görlich Gruppe leads investment rounds.

Similar investors

Featured in lists